NCT02006095

Brief Summary

Carotid revascularization can significantly reduce the risk of stroke in patients with severe carotid stenosis; however, it has been associated with cognitive decline in 25% of the older adults who undergo the procedure. Characterizing risk factors for cognitive decline following carotid interventions and individualizing treatment strategy based on those risks can minimize procedure-associated cognitive dysfunction. Neuroimaging techniques that characterize white matter integrity and regional hypoperfusion have the potential to provide sensitive brain structure indicators that may be associated with memory decline following revascularization procedures. In this protocol, we hope to determine how cerebral blood flow and baseline white matter abnormality in the vulnerable region modify the frequency and cognitive effect of microembolization following carotid revascularization procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
207

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2012

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

December 9, 2013

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

August 29, 2022

Status Verified

August 1, 2022

Enrollment Period

5.4 years

First QC Date

October 29, 2012

Last Update Submit

August 24, 2022

Conditions

Keywords

carotid artery stentingcarotid endarterectomymagnetic resonance imaging (MRI)neuropsychological testingmicroemboli

Outcome Measures

Primary Outcomes (1)

  • Brain MRI scans

    White matter abnormality and perfusion in correlation with microembolization and cognitive change

    6 months following the procedure

Study Arms (1)

Neuroimaging Correlates

Other: Magnetic resonance imagingBehavioral: Neuropsychological testing

Interventions

arterial spin labeling, diffusion tensor imaging, and diffusion weighted imaging sequences will be used

Neuroimaging Correlates
Neuroimaging Correlates

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing carotid intervention

You may qualify if:

  • Patient is male or female \>40 yrs of age.
  • Patient has occlusive extracranial carotid stenosis (≥70%)
  • Patient is scheduled to undergo a carotid revascularization procedure
  • Patient agrees to voluntarily participate in the study and signs an informed consent.
  • Patient agrees to be available for follow-up and is able to participate in all study testing procedures.
  • Patient has sufficient visual and auditory acuity for cognitive testing.

You may not qualify if:

  • Patient is unable to safely and comfortably undergo MR imaging procedures (e.g., claustrophobia, implanted medical devices that are MRI incompatible such as pacemaker, defibrillator, neural stimulator etc)
  • Patient has an untreated or unsuccessfully controlled psychiatric disease (schizophrenia, bipolar disorder).
  • Patient has prominent suicidal or homicidal ideation.
  • Patient has acute illness or unstable chronic illness (e.g. uncontrolled hypertension, hepatic encephalopathy, portal hypertension, ascites, and esophageal varices, pancreatitis).
  • Patient with a history of neurological (e.g., multiple sclerosis, seizure disorder, Parkinson's disease) or systemic illness affecting central nervous system function.
  • Patient has prior closed head injury with ≥24 hours of amnesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Palo Alto Veterans Affairs

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

Carotid Stenosis

Interventions

Magnetic Resonance SpectroscopyNeuropsychological Tests

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesPsychological TestsBehavioral Disciplines and Activities

Study Officials

  • Wei Zhou, MD

    Palo Alto Veterans Affairs/Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2012

First Posted

December 9, 2013

Study Start

November 1, 2012

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

August 29, 2022

Record last verified: 2022-08

Locations